We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$69.3M
(+15%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
688
New
58
Increased
157
Reduced
267
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$60M |
| 2 |
PepsiCo
PEP
|
+$9.31M |
| 3 |
TechnipFMC
FTI
|
+$8.19M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
+$7.88M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$14.4M |
| 2 |
Stellantis
STLA
|
+$8.39M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$7.31M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$6.57M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.57% |
| 2 | Technology | 5.11% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Materials | 4.47% |
| 5 | Energy | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Check Point Software Technologies
CHKP
$13.3B
| $23.4K | ﹤0.01% |
205
+5
| +3% | +$550 |
|
352
DuPont de Nemours
DD
$18.6B
| $23.3K | ﹤0.01% |
133
+34
| +34% | +$5.67K |
|
353
Four Corners Property Trust
FCPT
$2.86B
| $21.6K | ﹤0.01% |
869
| – | – |
|
|
CERN
354
DELISTED
Cerner Corp
CERN
| $20.3K | ﹤0.01% |
285
-54
| -16% | -$3.58K |
|
|
CLGX
355
DELISTED
Corelogic, Inc.
CLGX
| $19.3K | ﹤0.01% |
418
-42
| -9% | -$1.91K |
|
356
BBVA Argentina
BBAR
$3.85B
| $19.3K | ﹤0.01% |
947
+173
| +22% | +$2.99K |
|
|
MNK
357
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $19.2K | ﹤0.01% |
514
+501
| +3,854% | +$19.9K |
|
358
F5
FFIV
$22.1B
| $19.2K | ﹤0.01% |
159
-30
| -16% | -$3.62K |
|
|
TIF
359
DELISTED
Tiffany & Co.
TIF
| $19K | ﹤0.01% |
207
-93
| -31% | -$8.52K |
|
360
JPMorgan Chase
JPM
$939B
| $18.8K | ﹤0.01% |
197
+19
| +11% | +$1.75K |
|
361
Amplify Cybersecurity ETF
HACK
$2.63B
| $18.1K | ﹤0.01% |
601
+369
| +159% | +$11K |
|
362
PUT
Boeing
BA
$165B
| $17.4K | ﹤0.01% |
+250
| New | +$58.3K |
|
363
BioMarin Pharmaceuticals
BMRN
$11.5B
| $16K | ﹤0.01% |
+172
| New | +$15.2K |
|
364
Monster Beverage
MNST
$91.4B
| $16K | ﹤0.01% |
578
-582
| -50% | -$15.7K |
|
|
NVO
365
Novo Nordisk
NVO
$216B
| $15.7K | ﹤0.01% |
652
-182
| -22% | -$4.11K |
|
366
Allstate
ALL
$66.9B
| $15.3K | ﹤0.01% |
167
+84
| +101% | +$7.64K |
|
|
PFPT
367
DELISTED
Proofpoint, Inc.
PFPT
| $14.9K | ﹤0.01% |
171
-15
| -8% | -$1.33K |
|
368
AutoZone
AZO
$48.3B
| $14.9K | ﹤0.01% |
25
| – | – |
|
369
Huntsman Corp
HUN
$2.24B
| $14.8K | ﹤0.01% |
540
+342
| +173% | +$9.11K |
|
370
PUT
Tesla
TSLA
$1.24T
| $14.5K | ﹤0.01% |
750
| – | – |
|
371
Becton Dickinson
BDX
$43.1B
| $14.5K | ﹤0.01% |
76
+39
| +105% | +$7.56K |
|
|
SPLK
372
DELISTED
Splunk Inc
SPLK
| $14.5K | ﹤0.01% |
218
-22
| -9% | -$1.38K |
|
373
L3Harris
LHX
$55.9B
| $14.2K | ﹤0.01% |
108
-179
| -62% | -$21.5K |
|
374
Cencora
COR
$60.3B
| $14.1K | ﹤0.01% |
171
-15
| -8% | -$1.27K |
|
|
ESV
375
DELISTED
Ensco Rowan plc
ESV
| $13.9K | ﹤0.01% |
581
-114
| -16% | -$2.27K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2017 Portfolio in Review
As of Q3 2017, Exane Derivatives held 688 positions worth $535M, up 15% from $466M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Exane Derivatives deployed $21.1M of net new capital in Q3 2017, opening 58 new positions and adding to 157 existing holdings. Its largest new stake was PepsiCo: 80,581 shares worth $8.98M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Deutsche Bank, an estimated $14.4M trimmed.
- Exane Derivatives's largest Q3 2017 buy was PepsiCo: 80,581 shares worth $8.98M.
- Exane Derivatives added most to UBS Group in Q3 2017, an estimated $60M increase.
- Exane Derivatives's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $14.4M.
- Exane Derivatives fully exited Stellantis in Q3 2017, selling an estimated $8.39M.
- Exane Derivatives's ten largest holdings make up 50% of its $535M portfolio in Q3 2017.
- Exane Derivatives opened 58 new positions and closed 121 in Q3 2017.
- Exane Derivatives's portfolio value rose 15% quarter-over-quarter to $535M.
Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.